Literature DB >> 18037968

Insulin decreases inflammatory signal transcription factor expression in primary human liver cells after LPS challenge.

Marc G Jeschke1, Dagmar Klein, Wolfgang E Thasler, Ulrich Bolder, Hans-Jürgen Schlitt, Karl-Walter Jauch, Thomas S Weiss.   

Abstract

Hepatic homeostasis is essential for survival in critically ill and burned patients. Insulin administration improves survival and decreases infections in these patients. To determine the molecular mechanisms, the aim of the present study was to establish a stress model using primary human hepatocytes (PHHs) and to study the effects of insulin on the hepatic inflammatory signaling cascade. Liver tissue was obtained from general surgical patients, and PHHs were isolated and maintained in culture. Primary hepatocyte cultures were challenged with various doses of lipopolysaccharide (LPS), and the inflammatory signal transcription cascade was determined by real-time PCR. In subsequent experiments, primary hepatocyte cultures were challenged with LPS and insulin was added in various doses. Glucose was determined by colorimetric assays. PHHs treated with 100 microg/mL LPS showed a profound inflammatory reaction with increased expression of interleukin (IL)-6, IL-10, IL-1beta, tumor necrosis factor (TNF), and signal transducer and activator of transcription 5 (STAT-5). Insulin at 10 IU/mL significantly decreased IL-6, TNF, and IL-1beta at pretranslational levels, an effect associated with decreased STAT-5 mRNA expression (P < 0.05). Glucose concentration and cellular metabolic activity were not different between controls and insulin-treated cells. Based on our results, we suggest that primary hepatocyte cultures can be used to study the effect of LPS on the inflammatory cascade. Insulin decreases hepatic cytokine expression, which is associated with decreased STAT-5 expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18037968      PMCID: PMC2082131          DOI: 10.2119/2007-00062.Jeschke

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  40 in total

Review 1.  Insulin resistance, heart disease and inflammation. Identifying the 'at-risk' patient: the earlier the better? The role of inflammatory markers.

Authors:  Wolfgang Koenig
Journal:  Int J Clin Pract Suppl       Date:  2002-10

2.  Hepatocyte and kupffer cells co-cultured on micropatterned surfaces to optimize hepatocyte function.

Authors:  Yekaterina S Zinchenko; Laura W Schrum; Mark Clemens; Robin N Coger
Journal:  Tissue Eng       Date:  2006-04

3.  Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes.

Authors:  H Wang; J M Vishnubhakat; O Bloom; M Zhang; M Ombrellino; A Sama; K J Tracey
Journal:  Surgery       Date:  1999-08       Impact factor: 3.982

4.  Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?

Authors:  P Dandona; A Aljada; P Mohanty; H Ghanim; W Hamouda; E Assian; S Ahmad
Journal:  J Clin Endocrinol Metab       Date:  2001-07       Impact factor: 5.958

5.  Hyperglycemia induced by glucose infusion causes hepatic oxidative stress and systemic inflammation, but not STAT3 or MAP kinase activation in liver in rats.

Authors:  Pei-Ra Ling; Claudia Mueller; Robert J Smith; Bruce R Bistrian
Journal:  Metabolism       Date:  2003-07       Impact factor: 8.694

6.  Insulin treatment improves the systemic inflammatory reaction to severe trauma.

Authors:  Marc G Jeschke; Dagmar Klein; David N Herndon
Journal:  Ann Surg       Date:  2004-04       Impact factor: 12.969

7.  Changes in liver function and size after a severe thermal injury.

Authors:  Marc G Jeschke; Ronald P Micak; Celeste C Finnerty; David N Herndon
Journal:  Shock       Date:  2007-08       Impact factor: 3.454

Review 8.  Insulin in sepsis and septic shock.

Authors:  Undurti N Das
Journal:  J Assoc Physicians India       Date:  2003-07

9.  Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog.

Authors:  K J Tracey; S F Lowry; T J Fahey; J D Albert; Y Fong; D Hesse; B Beutler; K R Manogue; S Calvano; H Wei
Journal:  Surg Gynecol Obstet       Date:  1987-05

Review 10.  Insulin therapy for the critically ill patient.

Authors:  Greet Van den Berghe
Journal:  Clin Cornerstone       Date:  2003
View more
  9 in total

1.  Adiponectin upregulates hepatocyte CMKLR1 which is reduced in human fatty liver.

Authors:  Josef Wanninger; Sabrina Bauer; Kristina Eisinger; Thomas S Weiss; Roland Walter; Claus Hellerbrand; Andreas Schäffler; Akiko Higuchi; Kenneth Walsh; Christa Buechler
Journal:  Mol Cell Endocrinol       Date:  2011-11-18       Impact factor: 4.102

2.  Contributions of severe burn and disuse to bone structure and strength in rats.

Authors:  L A Baer; X Wu; J C Tou; E Johnson; S E Wolf; C E Wade
Journal:  Bone       Date:  2012-11-07       Impact factor: 4.398

Review 3.  Postburn Hypermetabolism: Past, Present, and Future.

Authors:  Marc G Jeschke
Journal:  J Burn Care Res       Date:  2016 Mar-Apr       Impact factor: 1.845

Review 4.  Burns: where are we standing with propranolol, oxandrolone, recombinant human growth hormone, and the new incretin analogs?

Authors:  Gerd G Gauglitz; Felicia N Williams; David N Herndon; Marc G Jeschke
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2011-03       Impact factor: 4.294

5.  Genome-wide transcriptome analysis identifies novel gene signatures implicated in human chronic liver disease.

Authors:  Rana V Smalling; Don A Delker; Yuxia Zhang; Natalia Nieto; Michael S McGuiness; Shuanghu Liu; Scott L Friedman; Curt H Hagedorn; Li Wang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-06-27       Impact factor: 4.052

6.  Low-dose plasmid DNA treatment increases plasma vasopressin and regulates blood pressure in experimental endotoxemia.

Authors:  Thiago Malardo; Marcelo E Batalhão; Ademilson Panunto-Castelo; Luciana P Almeida; Everton Padilha; Isabela C Fontoura; Célio L Silva; Evelin C Carnio; Arlete A M Coelho-Castelo
Journal:  BMC Immunol       Date:  2012-11-08       Impact factor: 3.615

7.  Helicobacter hepaticus induces an inflammatory response in primary human hepatocytes.

Authors:  Moritz Kleine; Tim Worbs; Harald Schrem; Florian W R Vondran; Alexander Kaltenborn; Jürgen Klempnauer; Reinhold Förster; Christine Josenhans; Sebastian Suerbaum; Hüseyin Bektas
Journal:  PLoS One       Date:  2014-06-16       Impact factor: 3.240

Review 8.  Clinical review: Glucose control in severely burned patients - current best practice.

Authors:  Marc G Jeschke
Journal:  Crit Care       Date:  2013-07-25       Impact factor: 9.097

Review 9.  From NAFLD to MAFLD: Aligning Translational In Vitro Research to Clinical Insights.

Authors:  Alexandra Gatzios; Matthias Rombaut; Karolien Buyl; Joery De Kock; Robim M Rodrigues; Vera Rogiers; Tamara Vanhaecke; Joost Boeckmans
Journal:  Biomedicines       Date:  2022-01-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.